Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bionomics Inc.

Division of Bionomics Ltd.
www.eclipsetherapeutics.com

Latest From Bionomics Inc.

New Company, Big Goal: Serial Entrepreneur Jonathan Lim Launches Erasca To 'Erase Cancer'

Lim, CEO of Ignyta when it was sold to Roche earlier this year, has moved on to the start-up Erasca with $42m in Series A venture cash to develop "precision oncology" drugs.

Financing Cancer

Phylogica Surges On Early CPP Cancer Results

Phylogica is continuing its strong financial year, with the company’s shares surging after it announced that a pilot study for its cell-penetrating peptides (CPPs) showed these were able to kill drug-resistant breast cancer cells in vivo, when linked with the cancer drug Omomyc.

BioPharmaceutical Australia

Deal Watch: Auxilium Joins The Tax-Inversion Wave As BIO Keeps The Deal Tide High

Endo expanded its generics business by purchasing Dava, EMD Serono partnered with Mersana on antibody-drug conjugates and Ligand in-licensed a cancer and autoimmune disease candidate from TG Therapeutics. It was all part of a hectic deal-making week coinciding with the annual BIO conference in San Diego.

BioPharmaceutical Deals

BIO 2014 Monday Round-Up: Let’s Make A Deal

The annual BIO conference opened in San Diego with deals being announced at the outset and everyone enthusiastic about partnering.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Eclipse Therapeutics Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Bionomics Ltd.
  • Senior Management
  • Jonathan Lim, MD, CEO
    Christopher Reyes, PhD, CSO
    Peter Chu, PhD, Pres.
  • Contact Info
  • Bionomics Inc.
    Phone: (858) 244-7870
    11575 Sorrento Valley Rd.
    Ste. 203
    San Diego, CA 92121
    USA
UsernamePublicRestriction

Register